The onco-embryonic antigen ROR1 is expressed by a variety of human cancers

American Journal of Pathology

Volumn 181, Issue 6, 2012, Pages 1903-1910

  Zhang, Suping ^a   Chen, Liguang ^a   Wang Rodriguez, Jessica ^a   Zhang, Ling ^a   Cui, Bing ^a   Frankel, Wendy ^b   Wu, Rongrong ^a   Kipps, Thomas J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FETAL ANTIGEN; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; ROR1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS;

EID: 84869166013     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.08.024     Document Type: Article

References (26)

1. G. Barna, R. Mihalik, B. Timar, J. Tombol, Z. Csende, A. Sebestyen, C. Bodor, B. Csernus, L. Reiniger, I. Petak, A. Matolcsy ROR1 expression is not a unique marker of CLL Hematol Oncol 29 2011 17 21
2. S. Baskar, K.Y. Kwong, T. Hofer, J.M. Levy, M.G. Kennedy, E. Lee, L.M. Staudt, W.H. Wilson, A. Wiestner, C. Rader Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia Clin Cancer Res 14 2008 396 404
3. A.H. Daneshmanesh, E. Mikaelsson, M. Jeddi-Tehrani, A.A. Bayat, R. Ghods, M. Ostadkarampour, M. Akhondi, S. Lagercrantz, C. Larsson, A. Osterborg, F. Shokri, H. Mellstedt, H. Rabbani Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy Int J Cancer 123 2008 1190 1195
4. T. Fukuda, L. Chen, T. Endo, L. Tang, D. Lu, J.E. Castro, G.F. Widhopf II, L.Z. Rassenti, M.J. Cantwell, C.E. Prussak, D.A. Carson, T.J. Kipps Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a Proc Natl Acad Sci U S A 105 2008 3047 3052
5. H. Rabbani, M. Ostadkarampour, A.H. Danesh Manesh, A. Basiri, M. Jeddi-Tehrani, F. Forouzesh Expression of ROR1 in patients with renal cancer-a potential diagnostic marker Iran Biomed J 14 2010 77 82
6. M. Shabani, H. Asgarian-Omran, M. Jeddi-Tehrani, P. Vossough, M. Faranoush, R.A. Sharifian, G.R. Toughe, M. Kordmahin, J. Khoshnoodi, A. Roohi, N. Tavoosi, H. Mellstedt, H. Rabbani, F. Shokri Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia Tumour Biol 28 2007 318 326
7. M. Hudecek, T.M. Schmitt, S. Baskar, M.T. Lupo-Stanghellini, T. Nishida, T.N. Yamamoto, M. Bleakley, C.J. Turtle, W.C. Chang, H.A. Greisman, B. Wood, D.G. Maloney, M.C. Jensen, C. Rader, S.R. Riddell The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor Blood 116 2010 4532 4541
8. S. Zhang, L. Chen, B. Cui, H.Y. Chuang, J. Yu, J. Wang-Rodriguez, L. Tang, G. Chen, G.W. Basak, T.J. Kipps ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth PLoS One 7 2012 e31127
9. T. Yamaguchi, K. Yanagisawa, R. Sugiyama, Y. Hosono, Y. Shimada, C. Arima, S. Kato, S. Tomida, M. Suzuki, H. Osada, T. Takahashi NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma Cancer Cell 21 2012 348 361
10. A. Stacchini, M. Aragno, A. Vallario, A. Alfarano, P. Circosta, D. Gottardi, A. Faldella, G. Rege-Cambrin, U. Thunberg, K. Nilsson, F. Caligaris-Cappio MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation Leuk Res 23 1999 127 136
11. D.J. Giard, S.A. Aaronson, G.J. Todaro, P. Arnstein, J.H. Kersey, H. Dosik, W.P. Parks In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J Natl Cancer Inst 51 1973 1417 1423
12. P.J. DiSaia, J.G. Sinkovics, F.N. Rutledge, J.P. Smith Cell-mediated immunity to human malignant cells A brief review and further studies with two gynecologic tumors Am J Obstet Gynecol 114 1972 979 989
13. M. Lieber, J. Mazzetta, W. Nelson-Rees, M. Kaplan, G. Todaro Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas Int J Cancer 15 1975 741 747
14. J.J. Tate, T.G. Cooper Formalin can alter the intracellular localization of some transcription factors in Saccharomyces cerevisiae FEMS Yeast Res 8 2008 1223 1235
15. M. Damelin, K.G. Geles, M.T. Follettie, P. Yuan, M. Baxter, J. Golas, J.F. DiJoseph, M. Karnoub, S. Huang, V. Diesl, C. Behrens, S.E. Choe, C. Rios, J. Gruzas, L. Sridharan, M. Dougher, A. Kunz, P.R. Hamann, D. Evans, D. Armellino, K. Khandke, K. Marquette, L. Tchistiakova, E.R. Boghaert, R.T. Abraham, I.I. Wistuba, B.B. Zhou Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells Cancer Res 71 2011 4236 4246
16. S. Aggarwal, S.W. Kim, S.H. Ryu, W.C. Chung, J.S. Koo Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein Cancer Res 68 2008 981 988
17. J.C. Cheng, K. Kinjo, D.R. Judelson, J. Chang, W.S. Wu, I. Schmid, D.B. Shankar, N. Kasahara, R. Stripecke, R. Bhatia, E.M. Landaw, K.M. Sakamoto CREB is a critical regulator of normal hematopoiesis and leukemogenesis Blood 111 2008 1182 1192
18. A. Chhabra, H. Fernando, G. Watkins, R.E. Mansel, W.G. Jiang Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis Oncol Rep 18 2007 953 958
19. N.M. Linnerth, J.B. Greenaway, J.J. Petrik, R.A. Moorehead cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation Int J Gynecol Cancer 18 2008 1248 1257
20. K.M. Sakamoto, D.A. Frank CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy Clin Cancer Res 15 2009 2583 2587
21. X. Xiao, B.X. Li, B. Mitton, A. Ikeda, K.M. Sakamoto Targeting CREB for cancer therapy: friend or foe Curr Cancer Drug Targets 10 2010 384 391
22. X. Zhang, D.T. Odom, S.H. Koo, M.D. Conkright, G. Canettieri, J. Best, H. Chen, R. Jenner, E. Herbolsheimer, E. Jacobsen, S. Kadam, J.R. Ecker, B. Emerson, J.B. Hogenesch, T. Unterman, R.A. Young, M. Montminy Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues Proc Natl Acad Sci U S A 102 2005 4459 4464
23. A. Bellacosa, C.C. Kumar, A. Di Cristofano, J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86
24. S. Zhang, L. Chen, B. Cui, H.Y. Chuang, J. Yu, J. Wang-Rodriguez, L. Tang, G. Chen, G.W. Basak, T.J. Kipps ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth PLoS One 7 2012 e31127
25. A. Gentile, L. Lazzari, S. Benvenuti, L. Trusolino, P.M. Comoglio Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis Cancer Res 71 2011 3132 3141
26. A. Choudhury, K. Derkow, A.H. Daneshmanesh, E. Mikaelsson, S. Kiaii, P. Kokhaei, A. Osterborg, H. Mellstedt Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells Br J Haematol 151 2010 327 335